RegeneRx Biopharmaceuticals, Inc. Financial Ratios — RGRX

Profitability (USD)

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Return on Common Equity (%)	-197.91	-156.48	-137.36	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-146.27	-123.62	-114.03	-260.52	-228.85	-336.22	-555.21	-806.25	37.54	52.59	-784.69	-282.89	-241.13	-173.98	-207.24
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-7.12	-9.47	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	- -	100	100	100	100	- -	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-6,393.46	- -	-591.19	-397.1	-62.09	-3,083.88	- -	-2,814.84	-1,790.51	-2,544.63	-1,895.61	-1,642.04	-1,686.46	-1,730.71	-1,826.44
Operating Margin (%)	-6,404.97	- -	-592.33	-397.7	-62.65	-3,100.84	- -	-2,820.46	-1,794.08	-2,550.01	-1,899.56	-1,643.89	-1,686.46	-1,730.71	-1,826.44
Incremental Operating Margin (%)	- -	-2,541.65	- -	- -	- -	- -	2,174.86	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	-397.4	-63.08	-2,276.97	- -	-8,695.44	245.56	679.75	-2,861.55	-1,829.35	-1,984.56	-2,081.47	-2,250.43
Profit Margin (%)	-6,316.04	- -	-591.37	-397.4	-63.08	-2,276.97	- -	-8,695.44	245.56	505.7	-2,861.55	-1,829.35	-1,984.56	-2,081.47	-2,250.43
Net Income to Common Margin (%)	-6,316.04	- -	-591.37	-397.4	-63.08	-2,276.97	- -	-8,695.44	245.56	505.7	-2,861.55	-1,936.91	-1,984.56	-2,081.47	-2,250.43
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	25.61	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.55	- -	- -	- -
Sustainable Growth Rate (%)	-197.91	-156.48	-137.36	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Total Debt	- -	- -	- -	- -	- -	- -	1	1	1	1	- -	1	1	1	1
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	1	1	1	- -	- -	1	1	1	1
Total Debt/EBITDA	- -	- -	- -	- -	-0.33	-0.48	-0.37	-0.4	-0.49	-0.44	-0.04	-0.58	-0.79	-0.88	-1.03
Net Debt/EBITDA	0.53	0.67	0.75	0.02	-0.16	-0.47	0.18	-0.22	-0.03	-0.31	0.14	-0.05	-0.41	0.07	-0.77
Total Debt/EBIT	- -	- -	- -	- -	-0.33	-0.47	-0.36	-0.4	-0.49	-0.44	-0.04	-0.58	-0.79	-0.88	-1.03
Net Debt/EBIT	0.52	0.67	0.75	0.02	-0.16	-0.47	0.18	-0.22	-0.03	-0.31	0.14	-0.05	-0.41	0.07	-0.77
EBITDA to Interest Expense	- -	- -	- -	- -	-146.32	-9.01	-8.45	-9.87	-9.64	-8.44	-15.13	-8.22	-5.56	-4.09	-4.31
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	-146.32	-9.01	-8.52	-9.87	-9.64	-8.44	-15.13	-8.22	-5.56	-4.09	-4.31
EBIT to Interest Expense	- -	- -	- -	- -	-147.65	-9.06	-8.48	-9.89	-9.66	-8.45	-15.16	-8.23	-5.56	-4.09	-4.31
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	77.61	80.79	85.42	-111.33	-286.94	-3,794.54	-180.32	-1,882.18	-703.45	-1,812.76	-787.1	-328.78	-511.78	-173.54	-901.54
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-36.86	-36.38	-49.41	-11.38	-9.74	-1.26	- -	-44.12	-52.93	-106.77	-70.18
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	77.28	1,012.27	59.63	192.3	59.37	19.3	- -	99.48	172.45	88.49	367.09
Total Debt/Equity (%)	- -	- -	- -	- -	-26.93	-26.68	-33.07	-10.22	-13.39	-15.42	-2.48	-31.41	-36.34	-52.24	-41.98
Total Debt/Capital (%)	- -	- -	- -	- -	-36.86	-36.38	-49.41	-11.38	-15.45	-18.24	-2.54	-45.8	-57.09	-109.39	-72.35
Total Debt/Total Assets (%)	- -	- -	- -	- -	77.28	1,012.27	59.63	192.3	94.16	279.58	19.48	103.28	185.98	90.66	378.44
Net Debt to Equity	-123.03	-117.62	-104.95	27.18	-13.07	-26.29	16.24	-5.51	-0.7	-11.01	8.25	-2.91	-18.76	4.24	-31.4
Net Debt/Capital (%)	534.18	667.63	2,118.28	21.37	-15.03	-35.66	13.97	-5.83	-0.71	-12.37	7.62	-3.04	-23.8	4.11	-47.24
EBITDA	-11	-6	-5	-6	-1	-1	-2	-2	-2	-1	-1	-1	-1	-1	-1
EBITDA-CapEx	-11	-6	-5	-6	-1	-1	-2	-2	-2	-1	-1	-1	-1	-1	-1
Operating Income (Loss)	-11	-7	-5	-6	-1	-1	-2	-2	-2	-1	-1	-1	-1	-1	-1

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Cash Ratio	4.27	4.95	6.15	0.14	0.2	0.01	2.06	0.88	1.17	0.08	0.75	2.64	1.07	2.86	0.53
Current Ratio	4.44	5.17	6.79	0.44	0.48	0.05	2.27	0.95	1.29	0.1	0.87	2.81	1.2	2.91	0.55
Quick Ratio	4.27	4.95	6.16	0.41	0.45	0.01	2.06	0.88	1.17	0.08	0.75	2.64	1.07	2.86	0.53
CFO/Avg Current Liab	-5.57	-5.58	-6.68	-7.59	-0.36	-1.18	-3.32	-1.37	-2.1	-0.47	-0.72	-4.08	-3.14	-2.39	-1.91
Common Equity/Total Assets	77.61	80.79	85.42	-111.33	-286.94	-3,794.54	-180.32	-1,882.18	-703.45	-1,812.76	-787.1	-328.78	-511.78	-173.54	-901.54
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-36.86	-36.38	-49.41	-11.38	-9.74	-1.26	- -	-44.12	-52.93	-106.77	-70.18
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	77.28	1,012.27	59.63	192.3	59.37	19.3	- -	99.48	172.45	88.49	367.09
Total Debt/Equity (%)	- -	- -	- -	- -	-26.93	-26.68	-33.07	-10.22	-13.39	-15.42	-2.48	-31.41	-36.34	-52.24	-41.98
Total Debt/Capital (%)	- -	- -	- -	- -	-36.86	-36.38	-49.41	-11.38	-15.45	-18.24	-2.54	-45.8	-57.09	-109.39	-72.35
Total Debt/Total Assets (%)	- -	- -	- -	- -	77.28	1,012.27	59.63	192.3	94.16	279.58	19.48	103.28	185.98	90.66	378.44
CFO/Total Liabilities	-797.22	-698.73	-810.34	-668.59	-19.87	-46.97	-64.04	-7.4	-15.42	-15.27	-35.63	-37.29	-29.83	-28.17	-24.58
CFO/CapEx	- -	- -	-190.84	-4,999.99	- -	- -	-127.92	-488.23	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	5.14	-6.89	-16.62	-389.43	-380.44	-3,264.49	-148.66	-422.51	-173.3	-673.05	-538.13	-212.57	-272.21	-119.05	-420.63

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Accounts Receivable Turnover	12.5	- -	158.75	13.43	6.85	0.33	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	29.21	- -	2.3	27.18	53.25	1,097.76	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Market Capitalization	63	33	16	11	7	4	15	45	34	19	20	18	65	23	20
- Cash & Cash Equivalents	6	4	4	- -	- -	- -	1	- -	1	- -	- -	1	- -	1	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	1	1	1	1	- -	1	1	1	1
Enterprise Value	58	29	12	11	7	5	14	45	34	19	20	19	65	23	21
Total Capital	5	4	4	- -	-1	-1	-1	-6	-5	-3	-2	-2	-2	-1	-2
Total Debt/Capital (%)	- -	- -	- -	- -	-36.86	-36.38	-49.41	-11.38	-15.45	-18.24	-2.54	-45.8	-57.09	-109.39	-72.35
Total Debt / EV	- -	- -	- -	- -	0.04	0.09	0.04	0.02	0.02	0.03	- -	0.04	0.02	0.05	0.07
EV/Sales	342.13	- -	14.58	7.46	5.52	162.77	- -	743.96	363.59	337.45	283.13	241.08	850.92	298.35	274.81
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	60	31	15	11	7	4	13	45	40	21	19	18	65	22	20
Diluted Enterprise Value	54	26	11	11	7	5	13	45	40	21	19	18	65	22	21
EV per Share	107.45	47.79	16.85	13.86	9.06	5.87	14.13	44.37	31.77	17.41	15.36	14.07	48.95	15.95	14.69
TTM Sales	- -	- -	1	2	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-11	-6	-5	-6	-1	-1	-2	-2	-2	-1	-1	-1	-1	-1	-1
TTM Operating Income	-11	-7	-5	-6	-1	-1	-2	-2	-2	-1	-1	-1	-1	-1	-1
TTM Cash Flow to Firm	- -	- -	- -	-5	- -	-1	-2	- -	-1	-1	-1	-1	-1	-1	-1
TTM Free Cash Flow to Firm	- -	- -	- -	-5	- -	-1	-2	- -	-1	-1	-1	-1	-1	-1	-1

Multiples (USD)

Valuation Multiples API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Price/Free Cash Flow	-5.69	-4.98	-3.03	-2.07	-26.5	-5.59	-7.94	-85.21	-37.41	-31	-21.06	-16.11	-64.23	-22.39	-21.2
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	58	29	12	11	7	5	14	45	34	19	20	19	65	23	21
Low Price	64	31	19.5	7	6.66	4.25	5	13.01	25	13.9	8.75	7	14	14.5	10
EV/Sales	342.13	- -	14.58	7.46	5.52	162.77	- -	743.96	363.59	337.45	283.13	241.08	850.92	298.35	274.81
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	147.88	63.76	- -	- -	- -	- -	- -
Price/Earnings Average	-5.72	-5.8	-5.3	-2.86	-13.75	-9.4	-5.66	-7.04	206.01	106.15	-11.86	-14.4	-32.68	-25.72	-14.85
Price/Earnings High	-9.49	-16.72	-10.76	-4.27	-23.13	-14.37	-9.64	-11.56	349.55	142.51	-18.47	-30.83	-65.66	-71.13	-24.93
Price/Earnings Low	-3.07	-2.66	-2.66	-0.93	-6.42	-5.17	-1.69	-2.51	116.52	52.13	-5.3	-6.17	-12.26	-12.58	-8.31
Price/Book Value	13.77	8.97	4.48	-26.68	-7.11	-2.7	-8.52	-6.63	-5.59	-4.53	-9	-7.87	-22.92	-10.3	-5.79
Price/Book Value Average	13.93	11.04	7.91	-40.87	-11.39	-3.89	-9.9	-5.51	-7.78	-7.55	-11.37	-9.18	-17.64	-19.09	-7.45
Price/Book Value High	23.1	31.81	16.09	-60.99	-19.17	-5.95	-16.87	-9.04	-13.2	-10.14	-17.71	-19.67	-35.44	-52.79	-12.5
Price/Book Value Low	7.47	5.06	3.97	-13.34	-5.32	-2.14	-2.96	-1.96	-4.4	-3.71	-5.08	-3.93	-6.62	-9.33	-4.17
Price/Tangible Book Value	13.77	8.97	4.48	-26.68	-7.11	-2.7	-8.52	-6.63	-5.59	-4.53	-9	-7.87	-22.92	-10.3	-5.79
Price/Tangible Book Value Average	13.93	11.04	7.91	-40.87	-11.39	-3.89	-9.9	-5.51	-7.78	-7.55	-11.37	-9.18	-17.64	-19.09	-7.45
Price/Tangible Book Value High	23.1	31.81	16.09	-60.99	-19.17	-5.95	-16.87	-9.04	-13.2	-10.14	-17.71	-19.67	-35.44	-52.79	-12.5
Price/Tangible Book Value Low	7.47	5.06	3.97	-13.34	-5.32	-2.14	-2.96	-1.96	-4.4	-3.71	-5.08	-3.93	-6.62	-9.33	-4.17
Price/Sales	357.11	- -	17.72	7.42	5.41	148.31	- -	737.02	363.14	322.41	268.58	238.87	842.59	288.88	259.75
Price/Sales Average	361.26	- -	31.31	11.37	8.67	214.1	- -	612.51	505.87	536.79	339.37	278.82	648.46	535.31	334.22
Price/Sales High	599.22	- -	63.65	16.96	14.59	327.11	- -	1,005.02	858.34	720.69	528.49	597.17	1,302.98	1,480.52	561.03
Price/Sales Low	193.69	- -	15.71	3.71	4.05	117.82	- -	217.92	286.11	263.62	151.62	119.43	243.22	261.8	187.01
Price/Cash Flow	-5.69	-4.98	-3.01	-2.07	-26.5	-5.59	-7.88	-85.03	-31.72	-27.55	-21.06	-16.11	-64.23	-22.39	-21.2
Price/Cash Flow Average	-5.76	-6.12	-5.32	-3.17	-42.47	-8.08	-9.15	-70.67	-44.19	-45.86	-26.62	-18.81	-49.43	-41.49	-27.27
Price/Cash Flow High	-9.55	-17.65	-10.82	-4.73	-71.45	-12.34	-15.59	-115.96	-74.98	-61.57	-41.45	-40.28	-99.33	-114.76	-45.78
Price/Cash Flow Low	-3.09	-2.81	-2.67	-1.03	-19.83	-4.44	-2.73	-25.14	-24.99	-22.52	-11.89	-8.06	-18.54	-20.29	-15.26
Price/Free Cash Flow Average	-5.76	-6.12	-5.35	-3.17	-42.47	-8.08	-9.22	-70.81	-52.11	-51.62	-26.62	-18.81	-49.43	-41.49	-27.27
Price/Free Cash Flow High	-9.55	-17.65	-10.88	-4.73	-71.45	-12.34	-15.71	-116.19	-88.42	-69.3	-41.45	-40.28	-99.33	-114.76	-45.78
Price/Free Cash Flow Low	-3.09	-2.81	-2.69	-1.04	-19.83	-4.44	-2.76	-25.19	-29.47	-25.35	-11.89	-8.06	-18.54	-20.29	-15.26
EV/Sales Average	346.49	- -	29.18	11.47	8.78	228.56	- -	619.31	506.33	556.52	358.45	281.2	656.66	553.59	349.27
EV/Sales High	596.85	- -	63.92	17.15	14.71	341.57	- -	1,012.26	858.8	744.43	559.65	600.85	1,311.6	1,532.6	576.08
EV/Sales Low	170.2	- -	12.42	3.69	4.15	132.27	- -	224.29	286.57	277.38	158.69	121.16	251.17	270.29	202.06
EV/EBITDA Average	-5.42	-5.63	-4.94	-2.89	-14.14	-7.41	-10.75	-22	-28.28	-21.87	-18.91	-17.12	-38.94	-31.99	-19.12
EV/EBITDA High	-9.34	-17.48	-10.81	-4.32	-23.69	-11.08	-18.44	-35.96	-47.96	-29.25	-29.52	-36.59	-77.77	-88.55	-31.54
EV/EBITDA Low	-2.66	-2.21	-2.1	-0.93	-6.69	-4.29	-3.09	-7.97	-16	-10.9	-8.37	-7.38	-14.89	-15.62	-11.06
EV/EBIT Average	-5.41	-5.61	-4.93	-2.88	-14.02	-7.37	-10.72	-21.96	-28.22	-21.82	-18.87	-17.11	-38.94	-31.99	-19.12
EV/EBIT High	-9.32	-17.44	-10.79	-4.31	-23.47	-11.02	-18.38	-35.89	-47.87	-29.19	-29.46	-36.55	-77.77	-88.55	-31.54
EV/EBIT Low	-2.66	-2.21	-2.1	-0.93	-6.63	-4.27	-3.08	-7.95	-15.97	-10.88	-8.35	-7.37	-14.89	-15.62	-11.06
Last Price	118	55	22	14	8.9	5.35	14.4	44	31.73	17	15.5	14	48.5	16	13.89
High Price	198	195	79	32	24	11.8	28.5	60	75	38	30.5	35	75	82	30
Enterprise Value Average	58	37	25	17	12	7	17	38	47	32	25	22	50	42	27
Enterprise Value High	101	113	54	26	20	10	29	61	80	42	39	46	101	118	44
Enterprise Value Low	29	14	11	6	6	4	5	14	27	16	11	9	19	21	16

Shares Outstanding	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Diluted Weighted Avg Shares	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Basic Weighted Avg Shares	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Revenue per Share	0.33	- -	1.24	1.89	1.65	0.04	- -	0.06	0.09	0.05	0.06	0.06	0.06	0.06	0.05
EBITDA per Share	-21.13	-11.66	-7.34	-7.49	-1.02	-1.11	-1.66	-1.68	-1.56	-1.34	-1.09	-0.96	-0.97	-0.96	-0.98
Operating Income per Share	-21.16	-11.69	-7.35	-7.5	-1.03	-1.12	-1.67	-1.68	-1.57	-1.34	-1.1	-0.96	-0.97	-0.96	-0.98
Basic EPS, GAAP	-20.87	-11.66	-7.34	-7.5	-1.04	-0.82	-2.95	-5.19	0.21	0.27	-1.65	-1.14	-1.14	-1.15	-1.2
Basic EPS from Cont Ops	-20.87	-11.66	-7.34	-7.5	-1.04	-0.82	-2.95	-5.19	0.21	0.27	-1.65	-1.07	-1.14	-1.15	-1.2
Diluted EPS, GAAP	-20.87	-11.66	-7.34	-7.5	-1.04	-0.82	-2.95	-5.19	0.18	0.24	-1.65	-1.14	-1.14	-1.15	-1.2
Diluted EPS from Cont Ops	-20.87	-11.66	-7.34	-7.5	-1.04	-0.82	-2.95	-5.19	0.18	0.24	-1.65	-1.07	-1.14	-1.15	-1.2
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-20.74	-11.05	-7.3	-6.76	-0.34	-0.96	-1.83	-0.52	-1	-0.62	-0.74	-0.87	-0.76	-0.71	-0.66
Free Cash Flow per Basic Share	-20.74	-11.05	-7.34	-6.76	-0.34	-0.96	-1.84	-0.52	-1	-0.62	-0.74	-0.87	-0.76	-0.71	-0.66
Cash & Equivalents per Share	10.55	7.21	5.15	0.14	0.17	0.01	0.83	0.31	0.72	0.17	0.18	0.49	0.32	0.86	0.2
Book Value per Share	8.57	6.13	4.91	-0.52	-1.25	-1.98	-1.69	-6.63	-5.68	-3.75	-1.72	-1.78	-2.12	-1.55	-2.4
Tangible Book Value per Share	8.57	6.13	4.91	-0.52	-1.25	-1.98	-1.69	-6.63	-5.68	-3.75	-1.72	-1.78	-2.12	-1.55	-2.4

RegeneRx Biopharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)